The healthcare sector has incredibly advanced in the past few years, with the launch of novel therapeutics and treatment modalities that have been successful in reducing mortality and morbidity rate even in cases of chronic illnesses. Hemodynamic monitoring is a popular method enabling the continuous monitoring of blood movement and pressure on the heart, arteries, and veins. The system also enables measuring the oxygen present in the blood. In the last few years, hemodynamic monitoring systems have emerged as an efficient method of collecting and analyzing qualitative and quantitative cardiopulmonary functions.
Heart failure (HF) is challenging, costly, and a highly prevalent medical condition. Around the world, hospitalization following acute decompensation is often associated with high mortality and morbidity. Despite uncountable advances in the medical world and the application of evidence-based therapies, HF still remains a formidable challenge. The high incidence of repeat hospitalizations for acute decompensated HF (ADHF) also has a financial impact on resources and institutions. Hence, this has made the early and accurate diagnosis of an impending ADHF indispensable, yet there is a limited availability of sophisticated infrastructure to facilitate the outpatient setting.
Technological Advances to Boost Global Hemodynamic Monitoring System Market
Earlier, ADHF was diagnosed using invasive hemodynamic monitoring or physical exam findings at the time of hospital admission. However, thanks to the advent of device-based diagnostics and advances introduced in medical microelectronics, long-term ambulatory monitoring of patients complaining of heart failure has become possible. With time, the monitors used for the diagnosis have evolved from systems mounted on cardiac implantable electrophysiologic devices to discrete implantable hemodynamic monitors that transduce pulmonary artery or left atrial pressures. As technologies continue to evolve, devices such as hemodynamic monitoring systems will become more compact and their capabilities will grow. Furthermore, the increasing incidence of lifestyle ailments and the growing prevalence of respiratory disorders will boost the demand for screening of critical congenital heart diseases (CCHD), which in turn will fuel the demand for hemodynamic monitoring systems.
According to a report published by Persistence Market Research, the global hemodynamic monitoring systems market had a valuation of US$328.7 mn in 2014. By the end of 2021, the market is anticipated to reach US$508.4 mn. While North America accounted for the largest share in the global hemodynamic monitoring market, in the near future, Latin America and APAC will prove to be the most lucrative regional segments.
Get Sample Report: http://www.persistencemarketresearch.com/samples/4396
In future, implantable hemodynamic monitors and other devices may be used beyond their utility in diagnosing impending heart failure to include better management of chronic ailments such as end-stage renal disease, pulmonary hypertension, and portal hypertension.
Key Players Focusing On Expanding Operations in Emerging Economies
Key players operating in the global hemodynamic monitoring system market are investing increasingly on R&D to introduce more innovative products and gain a competitive edge in the market. Some of the prominent companies operating in the market include ICU Medical, Inc., Edwards Lifesciences Corporation, Teleflex Incorporated, PULSION Medical Systems SE, and LiDCO Group Plc. Some of these companies are also focusing on expanding their operations regionally through mergers and acquisitions. While in developed economies, manufacturers prefer selling products directly to the consumer, in developing nations such as China, they prefer tying up with local suppliers to enhance their reach.